Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
98.73 -0.69 / -0.69%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
98.73 0.00 / 0.00%
 
Volume: 3.2K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Operating ActivitiesNet Income / Starting Line-30.7M-36.4M-50.2M-48.3M
 
 
 
 
 
Depreciation1.6M1.4M1.7M1.3M
 
 
 
 
 
Total Other Cash Flow3.5M3.9M5.2M7.9M
 
 
 
 
 
Funds From Operations-25.6M-31.1M-43.3M-39.1M
 
 
 
 
 
Funds From/For Other Operating Expenses759.0K2.9M-7.7M998.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-26.4M-34.0M-35.6M-40.1M
 
 
 
 
 
 
InvestingIncrease In Investments-199.2M-167.6M-141.3M-109.3M
 
 
 
 
 
Decrease In Investments70.5M90.7M95.1M160.5M
 
 
 
 
 
Capital Expenditures-2.3M-3.2M-5.6M-5.2M
 
 
 
 
 
Other Investing - Uses933.0K0.000.00-216.0K
 
 
 
Other Investing - Sources--320.0K0.00-320.0K
 
 
 
Net Cash Flow Investing-130.1M-79.9M-51.9M45.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale1.7M204.1M5.6M884.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.0095.0K
 
 
Net Cash Flow - Financing1.7M204.1M5.6M789.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash26.0K-5.0K-13.0K-54.0K
 
 
 
 
 
 
Net Change In Cash-154.8M90.2M-81.9M6.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account